NFKB1 and chronic obstructive pulmonary disease: The mechanism of action may be related to the inhibition of inflammatory mediators such as IL-6 and TNF-α release and the regulation of NF-κB signalling pathway activity, which provides a new pharmacological basis for the improvement of respiratory symptoms in COPD patients by plant polyphenols.